ID

42665

Description

Atrasentan Spermatogenesis and Testicular Function; ODM derived from: https://clinicaltrials.gov/show/NCT02118714

Link

https://clinicaltrials.gov/show/NCT02118714

Keywords

  1. 11/20/15 11/20/15 -
  2. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Nephropathy NCT02118714

Eligibility Nephropathy NCT02118714

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
males 30 to 75 years of age
Description

Patient is male

Data type

boolean

Alias
UMLS CUI [1]
C0150904
type 1 or 2 diabetes and has been treated with at least one anti-hyperglycemic medication and angiotensin-converting enzyme inhibitors (acei)/angiotensin receptor blockers (arb) (renin-angiotensin system [ras] inhibitor) for at least 2 months prior to screening
Description

Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0877206
estimated glomerular filtration rate (egfr) equal to or greater than 50 ml/min with the chronic kidney disease epidemiology collaboration (ckd-epi) formula and urine albumin-to-creatinine ratio (uacr) equal to or greater than 30 and less than 5,000 mg/g creatinine.
Description

Estimated glomerular filtration rate

Data type

boolean

Alias
UMLS CUI [1]
C3811844
UMLS CUI [2]
C0455271
able to provide a semen specimen at the required intervals.
Description

Semen specimen

Data type

boolean

Alias
UMLS CUI [1]
C0278355
baseline sperm concentration ≥ 30 million per ml.
Description

Baseline sperm concentration

Data type

boolean

Alias
UMLS CUI [1]
C0429845
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with hormone suppressive agents or cancer chemotherapy within the past 6 months or planned during the study.
Description

Hormone suppressive agents

Data type

boolean

Alias
UMLS CUI [1]
C1535931
UMLS CUI [2]
C0392920
history of moderate or severe peripheral edema, pulmonary edema or facial edema unrelated to trauma or history of myxedema in the prior 6 months to screening.
Description

History of moderate or severe peripheral edema

Data type

boolean

Alias
UMLS CUI [1]
C0085649
UMLS CUI [2]
C0034063
UMLS CUI [3]
C0542571
history of pulmonary hypertension requiring either oxygen therapy and/or endothelin receptor antagonist or phosphodiesterase therapy or any lung disease requiring oxygen therapy.
Description

Pulmonary hypertension

Data type

boolean

Alias
UMLS CUI [1]
C0020542
documented diagnosis of heart failure, previous hospitalization for heart failure or current or constellation of symptoms (dyspnea on exertion, pedal edema, orthopnea, paroxysmal nocturnal dyspnea) felt to be compatible with heart failure, that was not explained by other causes, and for which there was a change in medication or other management directed at heart failure.
Description

Heart failure

Data type

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C3898876
history of hormone replacement therapy.
Description

Hormone replacement therapy

Data type

boolean

Alias
UMLS CUI [1]
C0282402
subject has evidence or history of hypogonadism.
Description

Hypogonadism

Data type

boolean

Alias
UMLS CUI [1]
C0020619

Similar models

Eligibility Nephropathy NCT02118714

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Patient is male
Item
males 30 to 75 years of age
boolean
C0150904 (UMLS CUI [1])
Diabetes Mellitus
Item
type 1 or 2 diabetes and has been treated with at least one anti-hyperglycemic medication and angiotensin-converting enzyme inhibitors (acei)/angiotensin receptor blockers (arb) (renin-angiotensin system [ras] inhibitor) for at least 2 months prior to screening
boolean
C0011849 (UMLS CUI [1,1])
C0877206 (UMLS CUI [1,2])
Estimated glomerular filtration rate
Item
estimated glomerular filtration rate (egfr) equal to or greater than 50 ml/min with the chronic kidney disease epidemiology collaboration (ckd-epi) formula and urine albumin-to-creatinine ratio (uacr) equal to or greater than 30 and less than 5,000 mg/g creatinine.
boolean
C3811844 (UMLS CUI [1])
C0455271 (UMLS CUI [2])
Semen specimen
Item
able to provide a semen specimen at the required intervals.
boolean
C0278355 (UMLS CUI [1])
Baseline sperm concentration
Item
baseline sperm concentration ≥ 30 million per ml.
boolean
C0429845 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hormone suppressive agents
Item
treatment with hormone suppressive agents or cancer chemotherapy within the past 6 months or planned during the study.
boolean
C1535931 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
History of moderate or severe peripheral edema
Item
history of moderate or severe peripheral edema, pulmonary edema or facial edema unrelated to trauma or history of myxedema in the prior 6 months to screening.
boolean
C0085649 (UMLS CUI [1])
C0034063 (UMLS CUI [2])
C0542571 (UMLS CUI [3])
Pulmonary hypertension
Item
history of pulmonary hypertension requiring either oxygen therapy and/or endothelin receptor antagonist or phosphodiesterase therapy or any lung disease requiring oxygen therapy.
boolean
C0020542 (UMLS CUI [1])
Heart failure
Item
documented diagnosis of heart failure, previous hospitalization for heart failure or current or constellation of symptoms (dyspnea on exertion, pedal edema, orthopnea, paroxysmal nocturnal dyspnea) felt to be compatible with heart failure, that was not explained by other causes, and for which there was a change in medication or other management directed at heart failure.
boolean
C0018801 (UMLS CUI [1])
C3898876 (UMLS CUI [2])
Hormone replacement therapy
Item
history of hormone replacement therapy.
boolean
C0282402 (UMLS CUI [1])
Hypogonadism
Item
subject has evidence or history of hypogonadism.
boolean
C0020619 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial